# Metagenomi (MGX) — Analyst Forecast

MGX · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/mgx/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 4 | 1 | 0 | 5 |

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Aug 11, 2026 | Wells Fargo | Maintained | Overweight | $7.00 |
| Jul 7, 2026 | Chardan Capital | Maintained | Buy | $5.00 |
| May 12, 2026 | Wells Fargo | Maintained | Overweight | $9.00 |
| Aug 19, 2025 | HC Wainwright & Co. | Maintained | Buy | $7.00 |
| Aug 15, 2025 | Chardan Capital | Maintained | Buy | $11.00 |
| Aug 14, 2025 | Wells Fargo | Maintained | Overweight | $12.00 |
| May 15, 2025 | Chardan Capital | Maintained | Buy | $12.00 |
| May 14, 2025 | Wells Fargo | Maintained | Overweight | $16.00 |
| Apr 3, 2025 | HC Wainwright & Co. | Maintained | Buy | $7.00 |
| Mar 18, 2025 | Wells Fargo | Maintained | Overweight | $20.00 |
| Dec 10, 2024 | HC Wainwright & Co. | Maintained | Buy | $14.00 |
| Nov 21, 2024 | HC Wainwright & Co. | Maintained | Buy | $7.00 |
| Nov 20, 2024 | Chardan Capital | Maintained | Buy | $15.00 |
| Oct 15, 2024 | HC Wainwright & Co. | Maintained | Buy | $7.00 |
| Sep 6, 2024 | HC Wainwright & Co. | Maintained | Buy | $7.00 |
| Sep 5, 2024 | Chardan Capital | Maintained | Buy | $15.00 |
| Aug 21, 2024 | HC Wainwright & Co. | Maintained | Buy | $7.00 |
| Aug 19, 2024 | Chardan Capital | Maintained | Buy | $15.00 |
| Aug 15, 2024 | BMO Capital | Maintained | Outperform | $17.00 |
| Jul 15, 2024 | HC Wainwright & Co. | Maintained | Buy | $10.00 |

## Frequently Asked Questions

### Is MGX a buy, sell, or hold?

Analysts covering Metagenomi currently average a Buy rating: 4 buy, 1 hold and 0 sell, from 5 analysts. Ratings reflect analyst opinion, not investment advice.

### What is the latest analyst rating on MGX?

On Aug 11, 2026, Wells Fargo maintained Metagenomi at Overweight with a price target of $7.00.

## Similar Stocks

- [MRNA](https://www.lighthorse.io/tickers/mrna) — Moderna, Inc. - Common Stock

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).